Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study

Background Although transcranial magnetic stimulation (TMS) can be an effective acute antidepressant treatment, few studies systematically examine persistence of benefit. Objective We assessed the durability of antidepressant effect after acute response to TMS in patients with major depressive disor...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Brain stimulation 2010-10, Vol.3 (4), p.187-199
Hauptverfasser:	Janicak, Philip G, Nahas, Ziad, Lisanby, Sarah H, Solvason, H. Brent, Sampson, Shirlene M, McDonald, William M, Marangell, Lauren B, Rosenquist, Peter, McCall, W. Vaughn, Kimball, James, O’Reardon, John P, Loo, Colleen, Husain, Mustafa H, Krystal, Andrew, Gilmer, William, Dowd, Sheila M, Demitrack, Mark A, Schatzberg, Alan F
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult antidepressant Antidepressive Agents - therapeutic use clinical trial Depressive Disorder, Major - prevention & control Depressive Disorder, Major - therapy Double-Blind Method Female Follow-Up Studies Humans Kaplan-Meier Estimate maintenance of effect major depression Middle Aged Neurology Prospective Studies Recurrence TMS Transcranial Magnetic Stimulation - methods Treatment Outcome treatment resistance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!